Table 1.

Clinical characteristic of the study participants.

Variable	Controls (n = 50)	Stable angina patients (n = 50)	Unstable angina patients (n = 50)	Controls vs. stable angina patients (p-value)	Controls vs. unstable angina patients (p-value)	Stable angina vs. unstable angina patients (p-value)
Age (year)	58.9±10.3	61.2±11.23	59.9±10.45	0.510	0.576	0.587
Men	35 (70%)	28 (56%)	32 (64%)	0.350	0.473	0.396
BMI (kg/m2)	26.9±0.6	27.8±1.5	26.89±1.3	0.387	0.483	0.376
Total Cholesterol (mg/dL)	178.3±47.0	192.9±36.3	199.5±55.8	0.123	0.073	0.214
Triglycerides (mg/dL)	147.4±36.3	159.3±80.5	161.9±95.6	0.112	0.073	0.231
LDL-cholesterol (mg/dL)	96.8±27.5	109.4±23.8	113.5±31.5	0.072	0.009	0.106
HDL-cholesterol (ng/dL)	46.1±9.5	44.7±9.6	41.8±11	0.108	0.099	0.444
hsCRP (mg/L)	1.9±1.3	3.2±1.4	4.0±1.7	<0.001	<0.001	0.031
Ox-LDL (ng/mL)	54.0±19.0	85.9±10.17	110.0±20	<0.001	<0.001	<0.001
Total NO (µmol/L)	103.0±21.0	74.3±22.0	54.5±19.0	<0.001	<0.001	<0.001
Adiponectin (µg/mL)	9.25±1.8	6.34±1.0	4.9±1.30	<0.001	<0.001	<0.001
Hypertension	3(6)	20(40)	20(40)	<0.001	<0.001	1.000
Diabetes mellitus	1(2)	12(24)	20(40)	<0.001	<0.001	<0.001
Family history of CAD	10(20)	20(40)	30(60)	<0.001	<0.001	0.001
Smoking	2(4)	8(16)	15(30)	<0.001	<0.001	<0.001
Statins	2(4)	18(36)	28(56)	<0.001	<0.001	<0.001
Aspirin	0(0)	28(56)	32(64)	<0.001	<0.001	0.156
Antiplatelets	0(0)	20(40)	20(40)	<0.001	<0.001	1.000
Nitrates	0(0)	15(30)	15(30)	<0.001	<0.001	1.000

Data are expressed as mean ± SD or number (%); BMI, body mass index; LDL-cholesterol, low density lipoprotein-cholesterol; HDL-cholesterol, high density lipoprotein-cholesterol; hsCRP, high sensitivity C-Reactive Protein; NO, nitric oxide; CAD, coronary artery disease.